22-10-2026 06:42 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  About Us   Services             Trading   Depository    
  You Are On: EQUITY
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
Company News
Aurobindo Pharma Ltd.
Change Company   
BSE Code 524804
ISIN Demat INE406A01037
Book Value 407.63
NSE Code AUROPHARMA
Dividend Yield % 0.25
Market Cap 906939.41
P/E 34.98
EPS 45.06
Face Value 1  
09-Oct-2026 Aurobindo Pharma informs about newspaper publicat...
05-Oct-2026 Aurobindo Pharma gets USFDA’s final nod to manufa...
05-Oct-2026 Aurobindo Pharma rises on getting USFDA’s final n...
03-Oct-2026 Aurobindo Pharma informs about acquisition
24-Sep-2026 Aurobindo Pharma informs about closure of trading...
16-Sep-2026 USFDA concludes inspection at Aurobindo Pharma’s ...
15-Sep-2026 Aurobindo Pharma gets USFDA’s nod for Beclomethas...
15-Sep-2026 Aurobindo Pharma informs about press release
11-Sep-2026 USFDA completes inspection at Aurobindo Pharma’s ...
02-Sep-2026 Aurobindo Pharma moves up as its arm incorporates...
01-Sep-2026 Aurobindo Pharma’s arm incorporates wholly owned ...
01-Sep-2026 Aurobindo Pharma informs about disclosure
31-Aug-2026 Aurobindo Pharma’s arm launches generic equivalen...
31-Aug-2026 Aurobindo Pharma informs about press release
31-Aug-2026 Aurobindo Pharma gains as its arm launches generi...
Page 1 of 5
Prev || Next
 
Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors
KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
Few Important Links: NSE | BSE | NSDL | CDSL | SEBI | MCX | NCDEX | FMC | RBI | AMFI | My Company GST Number | SCORES | DP 15 | BSE PLUS
Contact Us | Careers | Downloads | Notice |Margin Obligation Circular |Creating Investor | Policies| Details of KMPS | Public information for Investors
Circular | BOI UPI ID & QR Code | Research Analyst Certificate | Internal policy RA
SEBI Reg. No INZ000209538 Depository CDSL: IN-DP-15-2015 Research Reg. No.: INH000011219
© 2006 J G Shah Financial Consultants Pvt.Ltd. All rights reserved.
Designed || Developed & Content Powerd By Accord Fintech Pvt. Ltd.